Oncocytoma as a growing FDG-avid adrenal mass on serial 18F-FDG PET/CT imaging: a potential pitfall in oncological evaluation / Masa suprarrenal captante de FDG que incrementa de tamaño en 18F-FDG PET/TC de seguimiento correspondiente a Oncocitoma: un posible pitfall en la evaluación oncológica

No disponible

Pregnant with metastatic neuroendocrine tumour of the ovary: what now?

Neuroendocrine tumours (NET) are a heterogeneous group of neoplasms commonly occurring in the gastrointestinal tract or lungs but can occur in other regions. Primary ovarian NET account for 5% of all NET and 0.1% of all ovarian malignancies. In metastatic disease, the therapeutic goal is to extend survival and to improve quality of life. As these tumours express somatostatin receptors, somatostatin analogues are frequently used to control symptoms. Here we present a case of a pregnant woman with an ovarian NET with liver metastases and carcinoid syndrome who was treated with the somatostatin analogue, Octreotide LAR. We also summarize reported data of the use of somatostatin analogues during pregnancy.